References
- Centers for Disease Control. Prescription drug overdose. http://www.cdc.gov/drugoverdose/. Accessed June 8, 2015.
- Krisberg K. Fatal heroin overdoses on increase as use skyrockets: health officials battling opiate epidemic. Nations Health. 2014;44(4):1–10. http://thenationshealth.aphapublications.org/content/44/4/1.1. Accessed February 17, 2015.
- Centers for Disease Control. Policy impact: prescription painkiller overdose. http://www.cdc.gov/drugoverdose/pdf/policyimpact-prescriptionpainkillerod-a.pdf. Published 2011. Accessed July 4, 2015.
- Grau LE, Green TC, Torban M, et al. Psychosocial and contextual correlates of opioid overdose risk among drug users in St. Petersburg, Russia. Harm Reduct J. 2009;4:6–17. doi: 10.1186/1477-7517-6-17.
- Milloy MJ, Fairbairn N, Hayashi K, et al. Overdose experiences among injection drug users in Bangkok, Thailand. Harm Reduct J. 2010;13:7–9. doi: 10.1186/1477-7517-7-9.
- Sergeev B, Karpets A, Sarang A, Tikhonov M. Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation. J Urban Health. 2003;80:212–219. doi: 10.1093/jurban/jtg024.
- Strang J1, Manning V, Mayet S, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008;103:1648–1657. doi: 10.1111/j.1360-0443.2008.02314.x.
- Sporer KA. Strategies for preventing heroin overdose. BMJ. 2003;326:442–444. doi: 10.1136/bmj.326.7386.442.
- Yealy DM, Paris PM, Kaplan RM, et al. The safety of pre-hospital naloxone administration by paramedics. Ann Emerg Med. 1990;19:902–905.
- Kim D, Irwin KS, Khoshnood K. Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. Am J Public Health. 2009;99:402–407. doi: 10.2105/AJPH.2008.136937.
- Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367:146–155. doi: 10.1056/NEJMra1202561.
- Wheeler E, Davidson PJ, Jones TS, Irwin KS. Community-based opioid overdose prevention programs providing naloxone—United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61:101–105. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6106a1.htm?s_cid=mm6106a1_w. Accessed July 3, 2015.
- Walley A, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:1–12.
- Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009;20:131–136.
- Hammett TM, Phan S, Gaggin J, et al. Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies and barriers in six countries. BMC Health Serv Res. 2014;14:1–11.
- National Institute on Drug Abuse. Nationwide trends. https://www.drugabuse.gov/publications/drugfacts/nationwide-trends. Updated June 2015. Accessed October 25, 2015.
- Swenson-Britt E, Carrougher G, Martin BW, Brackley M. Project HOPE: changing care delivery for the substance abuse patient. Clin Nurse Spec. 2000;14:92–100.
- Maryland Department of Health and Mental Hygiene. Hospital utilization of deaths in 2013. http://bha.dhmh.maryland.gov/OVERDOSE_PREVENTION/SitePages/Data%20and%20Reports.aspx. Published 2014. Accessed February 17, 2015.
- Survey Research Laboratory at University of Illinois Chicago. Missed Opportunity: National Survey of Primary Care Physicians and Patients on Substance Abuse. http://www.casacolumbia.org/addiction-research/reports/national-survey-primary-care-physicians-patients-substance-abuse. Published 2000. Accessed February 18, 2015.
- Holland C. Barriers to identification of Problem Alcohol and Drug Use: Results of Statewide Focus Groups [master's thesis]. Pittsburgh, PA: University of Pittsburgh School of Public Health; 2007. http://d-scholarship.pitt.edu/8828/1/HollandC_etd2007.pdf. Accessed July 5, 2015.
- Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315–1321. doi: 10.1001/jama.2011.370.
- Bowman S, Eiserman J, Beletsky L, Stancliff S, Bruce RD. Reducing the health consequences of opioid addiction in primary care. Am J Med. 2013;126:565–571.
- Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose. Ann Intern Med. 2010;152:85–92. doi: 10.7326/0003-4819-152-2-201001190-00006.
- Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300:2613–2620.
- United States Department of Health and Human Services. Addressing Prescription Drug Abuse in the United States. Current Activities and Future Opportunities. http://www.cdc.gov/drugoverdose/pdf/hhs_prescription_drug_abuse_report_09.2013.pdf. Published September 2013. Accessed July 3, 2015.
- American Medical Association. AMA adopts new policies at annual meeting. http://www.ama-assn.org/ama/pub/news/news/2012-06-19-ama-adopts-new-policies.page. Published 2012. Accessed February 17, 2015.
- American Public Health Association. Reducing opioid overdose through education and naloxone distribution. http://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2014/07/16/13/08/reducing-opioid-overdose-through-education-and-naloxone-distribution. Published 2013. Accessed February 17, 2015.
- American Society of Addiction Medicine. Public Policy Statement on the Use of Naloxone for the Prevention of Drug Overdose Deaths. http://www.asam.org/docs/default-source/publicy-policy-statements/1naloxone-rev-8-14.pdf?sfvrsn=0. Published 2014. Accessed February 17, 2015.
- Maryland Department of Health and Mental Hygiene. “Dear Treatment Provider.” http://bha.dhmh.maryland.gov/OVERDOSE_PREVENTION/Documents/October2014%20Naloxone%20Expansion%20Letter_Treatment%20Provider.pdf. Published October 2014. Accessed February 17, 2015.
- Beletsky L, Ruthazer R, Macalino GE, Rich JD, Tan L, Burris S. Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. J Urban Health. 2007;84:126–36.
- Matheson C, Pflanz-Sinclair C, Aucott L, et al. Reducing drug related deaths: a pre-implementation assessment of knowledge, barriers and enablers for naloxone distribution through general practice. BMC Fam Pract. 2014;15:12. doi: 10.1186/1471-2296-15-12.
- Green TC, Bowman SE, Zaller ND, Ray M, Case P, Heimer R. Barriers to medical support for prescription naloxone as overdose antidote for lay responders. Subst Use Misuse. 2013;48:558–567. doi: 10.3109/10826084.2013.787099.
- Kirschner N, Ginsburg J, Sulmasy LS, Health and Public Policy Committee of the American College of Physicians. Prescription drug abuse: executive summary of a policy position paper from the American College of Physicians. Ann Intern Med. 2014;160:198–200. doi: 10.7326/M13-2209.
- Kim D, Irwin KS, Khoshnood K. Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. Am J Public Health. 2009;99:402–407.
- Isaacson JH, Fleming M, Kraus M, Kahn R, Mundt M. A National survey of training in substance use disorders in residency programs. J Stud Alcohol. 2000;61:912–915.
- Maryland Department of Health and Mental Hygiene. Maryland Opioid Overdose Prevention Plan. http://bha.dhmh.maryland.gov/OVERDOSE_PREVENTION/Documents/MarylandOpioidOverdosePreventionPlan2013%20(4).pdf. Published January 2013. Accessed October 25, 2015.
- Coffin PO, Fuller C, Vadnai L, Blaney S, Galea S, Vlahov D. Preliminary evidence of health care providers support for naloxone prescription as overdose fatality prevention strategy in New York City. J Urban Health. 2003;80:288–290.
- Van Wert MJ, Gatewood A, Andrada A. Perceived barriers to prescribing naloxone to third parties as an overdose prevention strategy: a qualitative study of academic physician and medical student attitudes. Poster presented at 10th National Harm Reduction Conference; October 23–26, 2014; Baltimore, Maryland.
- Qualtrics. Qualtrics. Version 62232. Provo, UT: Qualtrics; 2015. www.Qualtrics.com.
- StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp; 2013.
- Dresser M. Hogan unveils plan to fight heroin. Baltimore Sun. February 24, 2015. http://www.baltimoresun.com/news/maryland/politics/bs-md-hogan-heroin-20150224-story.html. Accessed October 24, 2015.
- Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009;20:131–136. doi: 10.1016/j.drugpo.2008.03.002.
- Sherman SG, Gann DS, Tobin KE, Latkin CA, Welsh C, Bielenson P. “The life they save may be mine”: diffusion of overdose prevention information from a city sponsored programme. Int J Drug Policy. 2009;20:137–142. doi: 10.1016/j.drugpo.2008.02.004.
- Schwartz RP, Gryczynski J, O'Grady KE, et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009. Am J Public Health. 2013;103:917–922. doi: 10.2105/AJPH.2012.301049.
- Alexander GC, Frattaroli S, Gielen AC, eds. The Prescription Opioid Epidemic: An Evidence-Based Approach. Baltimore, MD: Johns Hopkins Bloomberg School of Public Health; 2015. http://www.jhsph.edu/research/centers-and-institutes/center-for-drug-safety-and-effectiveness/opioid-epidemic-town-hall-2015/2015-prescription-opioid-epidemic-report.pdf. Published November 2015. Accessed December 14, 2015.